Stimulant use with opioid use disorder medication increases overdose risk for methadone but not buprenorphine/naloxone People receiving treatment for opioid use disorder sometimes also need medications for other conditions like ADHD. But do stimula…

BfArM. Liste der Fertigarzneimittel mit einer Verpflichtung zur regelmäßigen Datenübermittlung nach § 52b Abs. 3f AMG In der 11. Beiratssitzung vom 05.06.2023 ist die Erweiterung der am 21.10.2020 festgelegten Kriterien einstimmig beschlossen worde…

Approved medications for opioid use disorder : current update.  Soyka M.  Expert Opin Pharmacother. 2025 May 21:1-15. doi: 10.1080/14656566.2025.2507124. Epub ahead of print. PMID: 40370106. https://www.tandfonline.com/doi/full/10.1080/…

Relative risks of adverse effects across different opioid agonist treatments—A systematic review and meta-analysis. Meyer M, Strazdins E, Guessoum A, Westenberg JN, Appenzeller-Herzog C, Cattaneo MEGV, et al.  Addicti…

Opioid consumption frequency and its associations with potential life problems during opioid agonist treatment in individuals with prescription-type opioid use disorder: exploratory results from the OPTIMA Study.  Bouthillier A, Bastien G, McA…

Exploring the Lived Experiences of Medication for Opioid use Disorder Treatment: A Qualitative Study among a Crowdsourced Convenience Sample.  Victor G, Kheibari A, Strickland JC.  Community Ment Health J. 2025 Apr;61(3):411-419. doi: 10…